ScoreWhy is Dallah Healthcare Co. ?
1
Poor Management Efficiency with a low ROCE of 8.34%
- The company has been able to generate a Return on Capital Employed (avg) of 8.34% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 24.54% and Operating profit at 27.51% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 11.48% signifying low profitability per unit of shareholders funds
3
Flat results in Jun 25
- INTEREST COVERAGE RATIO(Q) Lowest at 452.86
- DIVIDEND PAYOUT RATIO(Y) Lowest at 40.72%
- RAW MATERIAL COST(Y) Grown by 9.58% (YoY)
4
With ROE of 12.61%, it has a very attractive valuation with a 3.65 Price to Book Value
- Over the past year, while the stock has generated a return of -22.93%, its profits have risen by 10.7% ; the PEG ratio of the company is 2.7
- At the current price, the company has a high dividend yield of 1.3
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Dallah Healthcare Co. should be less than 10%
- Overall Portfolio exposure to Hospital should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Hospital)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Dallah Healthcare Co. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Dallah Healthcare Co.
-23.22%
-0.94
28.87%
Saudi Arabia All Share TASI
-12.63%
-0.89
14.47%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
24.54%
EBIT Growth (5y)
27.51%
EBIT to Interest (avg)
5.79
Debt to EBITDA (avg)
3.71
Net Debt to Equity (avg)
0.72
Sales to Capital Employed (avg)
0.55
Tax Ratio
3.87%
Dividend Payout Ratio
41.40%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.34%
ROE (avg)
11.48%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
3.65
EV to EBIT
34.15
EV to EBITDA
25.59
EV to Capital Employed
2.53
EV to Sales
5.10
PEG Ratio
2.69
Dividend Yield
1.29%
ROCE (Latest)
7.40%
ROE (Latest)
12.61%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET SALES(Q)
Highest at SAR 1,062.43 MM
OPERATING PROFIT(Q)
Highest at SAR 209.86 MM
-9What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 452.86
DIVIDEND PAYOUT RATIO(Y)
Lowest at 40.72%
RAW MATERIAL COST(Y)
Grown by 9.58% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at 76.62 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 7.21%
INTEREST(Q)
Highest at SAR 46.34 MM
Here's what is working for Dallah Healthcare Co.
Net Sales
Highest at SAR 1,062.43 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (SAR MM)
Net Sales
At SAR 1,062.43 MM has Grown at 38.85%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (SAR MM)
Operating Profit
Highest at SAR 209.86 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (SAR MM)
Depreciation
Highest at SAR 62.14 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (SAR MM)
Depreciation
At SAR 62.14 MM has Grown at 37.87%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (SAR MM)
Here's what is not working for Dallah Healthcare Co.
Interest
At SAR 46.34 MM has Grown at 76.9%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SAR MM)
Interest Coverage Ratio
Lowest at 452.86
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest
Highest at SAR 46.34 MM
in the last five periods and Increased by 76.9% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SAR MM)
Debt-Equity Ratio
Highest at 76.62 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 7.21%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Dividend Payout Ratio
Lowest at 40.72%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Grown by 9.58% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
